Convira Pharmaceuticals Private Limited
About Convira Pharmaceuticals Private Limited
Data last updated:
Convira Pharmaceuticals Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 January 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74120UP2012PTC048613. Its GSTIN is 09AAECC7090D2ZN (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.1 Lakh. It is led by directors including Sujeet Sahu (Managing Director) and Payal Sahu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Raman Villa Apartment Flat No. 102 160 – E Block Shyam Nagar, Kanpur, Uttar Pradesh, India – 208013.
As per the financials filed for FY 2025, the company reported a revenue of ₹21.44 Lakh, a decline of 38% compared to the previous year. For the same year it recorded a net profit of ₹16,847 (net margin 0.8%) and EBITDA of ₹2.84 Lakh (EBITDA margin 13.2%). Revenue has declined at a compounded annual rate (CAGR) of 24% over three years and 18% over five years.
As per MCA filings, the company has open charges of ₹9.5 Lakh and satisfied charges of ₹20 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressRaman Villa Apartment Flat No. 102 160 – E Block Shyam Nagar, Kanpur, Uttar Pradesh, India – 208013
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Convira Pharmaceuticals Private Limited
The main business activity of Convira Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Convira Pharmaceuticals Private Limited FY 2025 filings available
Convira Pharmaceuticals Private Limited reported revenue of ₹21.44 Lakh (down 38% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Convira Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 18% over five years, including a 38% fall in the latest year. EBITDA fell 45% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Convira Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.84 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹16,847 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Convira Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Convira Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Convira Pharmaceuticals Private Limited
Convira Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hecure Products Private Limited | ₹21.58 Lakh (FY 2025) | •••• | •••• | 776.0% | •••• | Delhi, India |
| Indcare Pharmaceuticals Private Limited | ₹21.56 Lakh (FY 2024) | •••• | •••• | -82.0% | •••• | Jaipur, Rajasthan, India |
| Dr Pen Lifesciences Private Limited | ₹21.56 Lakh (FY 2024) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Darius Pharmaceuticals Private Limited | ₹21.51 Lakh (FY 2025) | •••• | •••• | 9.0% | •••• | New Abhishek, West Mumbai, Maharashtra, India |
| Medigrowth Pharmaceuticals Private Limited | ₹21.48 Lakh (FY 2023) | •••• | •••• | 64.0% | •••• | Navi Mumbai, Maharashtra, India |
| Convira Pharmaceuticals Private Limited this company | ₹21.44 Lakh (FY 2025) | •••• | •••• | -38.0% | •••• | Kanpur, Uttar Pradesh, India |
| Worldmed Life Sciences Private Limited | ₹21.43 Lakh (FY 2020) | •••• | •••• | -67.0% | •••• | Secunderabad, Telangana, India |
| J. K. Lifescience Private Limited | ₹21.42 Lakh (FY 2025) | •••• | •••• | -27.0% | •••• | Silvassa, Dadra and Nagar Haveli, India |
| Myeliyon Pharmaceutical Private Limited | ₹21.42 Lakh (FY 2021) | •••• | •••• | 8.0% | •••• | Chl, Opp W.E High (Mumbai), Maharashtra, India |
| Daswell Pharmaceuticals Private Limited | ₹21.4 Lakh (FY 2019) | •••• | •••• | •••• | Howrah, West Bengal, India | |
| Allioth Pharmaceuticals Private Limited | ₹21.39 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Convira Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Convira Pharmaceuticals Private Limited
Convira Pharmaceuticals Private Limited is audited by TRIPATHI & SHUKLA for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| TRIPATHI & SHUKLA | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Convira Pharmaceuticals Private Limited
Convira Pharmaceuticals has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Payal Sahu | Director | 30 Jan 2012 | 14 Years 8 Months | Current |
| Sujeet Sahu Also directs: Halcyon Drugs and Formulation Private Limited | Managing Director | 30 Jan 2012 | 14 Years 8 Months | Current |
| Rajesh Sahu Also directs: Halcyon Drugs and Formulation Private Limited | Director | 01 Apr 2025 | 1 Years 6 Months | Current |
| Brijesh Kumar Sahu Also directs: Halcyon Drugs and Formulation Private Limited | Director | 01 Apr 2025 | 1 Years 6 Months | Current |
Ownership and Shareholding of Convira Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Convira Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Sep 2021 | Others | ₹9.5 Lakh | Open |
| 27 Jul 2013 | Bank of India | ₹20 Lakh | Satisfied |
Total charge records: 2 View all charges
Legal Cases of Convira Pharmaceuticals Private Limited
Convira Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed. Status as checked on 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by an individual | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Convira Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Convira Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Convira Pharmaceuticals Private Limited
Convira Pharmaceuticals Private Limited has 6 board changes on record since 2012: 4 appointments and 2 cessations. The latest: Brijesh Kumar Sahu was appointed as Director on 01 Apr 2025.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Convira Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Convira Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Convira Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Convira Pharmaceuticals Private Limited
Convira Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECC7090D2ZN | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Convira Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Convira Pharmaceuticals Private Limited
Convira Pharmaceuticals is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 January 2012 (14+ years old) and is registered under CIN U74120UP2012PTC048613.
Convira Pharmaceuticals reported revenue of ₹21.44 Lakh for FY 2025 (down 38% YoY).
Convira Pharmaceuticals has 4 current directors:
- Sujeet Sahu - Managing Director
- Payal Sahu - Director
- Rajesh Sahu - Director
- Brijesh Kumar Sahu - Director
Convira Pharmaceuticals reported a net profit of ₹16,847 (net margin 0.8%) and EBITDA of ₹2.84 Lakh (EBITDA margin 13.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Convira Pharmaceuticals is -24% over three years and -18% over five years. In the latest year (FY 2025) revenue fell 38%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Convira Pharmaceuticals is 09AAECC7090D2ZN, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Convira Pharmaceuticals is U74120UP2012PTC048613. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Convira Pharmaceuticals has 1 court case on record: 1 filed against it.
Convira Pharmaceuticals was incorporated on 30 January 2012, making it 14+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Convira Pharmaceuticals by revenue are Hecure Products Private Limited, Indcare Pharmaceuticals Private Limited, Dr Pen Lifesciences Private Limited, Darius Pharmaceuticals Private Limited, Medigrowth Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Brijesh Kumar Sahu was appointed as Director on 01 Apr 2025. Rajesh Sahu was appointed as Director on 01 Apr 2025. Brijesh Agnihotri ceased to be Director on 16 Jun 2014. Convira Pharmaceuticals has 6 board changes on record in total.